Drug Type Small molecule drug, Liposomal Drug |
Synonyms Doxorubicin liposomal (Thermosome), DPPG2-TSL-DOX, THE-001 + [1] |
Target |
Action inhibitors |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Soft Tissue Sarcoma | Phase 1 | Germany | ![]() | - |
Bladder Cancer | Preclinical | Germany | ![]() | 21 Aug 2024 |
Breast Cancer | Preclinical | Germany | ![]() | 21 Aug 2024 |